Inflammatory pathways underlying atrial fibrillation

被引:157
|
作者
Friedrichs, Kai [3 ]
Klinke, Anna [1 ,2 ]
Baldus, Stephan [1 ,2 ]
机构
[1] Univ Heart Ctr Hamburg, Cardiovasc Res Ctr, D-20246 Hamburg, Germany
[2] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, D-20246 Hamburg, Germany
[3] Univ Heart Ctr Hamburg, Dept Electrophysiol, D-20246 Hamburg, Germany
关键词
C-REACTIVE PROTEIN; PULMONARY VEIN ISOLATION; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; OXIDATIVE STRESS; CARDIAC-SURGERY; STERILE PERICARDITIS; REDOX REGULATION; TRANSGENIC MICE; NADPH OXIDASE;
D O I
10.1016/j.molmed.2011.05.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pathophysiology of atrial fibrillation (AF) remains incompletely understood, despite its prevalence and contributing role in stroke and heart failure. Whereas previous studies have focused on the electrophysiological characteristics of AF, recent reports shed light on structural remodeling of the atria as a prerequisite for AF. Recent evidence suggests that atrial fibrosis is linked not only to stimulation of myocytes and fibroblasts, but also to the activation state of leukocytes. Recruitment of leukocytes with the release of reactive oxygen species, cytokines and growth factors is followed by increased matrix deposition, which leads to adverse atrial remodeling and suggests that inflammatory pathways are a prerequisite for AF. Here we review current evidence demonstrating the interrelation between inflammation and AF.
引用
收藏
页码:556 / 563
页数:8
相关论文
共 50 条
  • [41] Identification of anticancer drugs-induced atrial fibrillation and the underlying suspicious molecular pathways: an approach combining pharmacovigilance and pharmacodynamics
    Dolladille, C.
    Ropert, C.
    Sassier, M.
    Chretien, B.
    Fedrizzi, S.
    Alexandre, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 13 - 13
  • [42] A patient with inflammatory arthralgia, paraesthesia and atrial fibrillation
    Vossen, D.
    Nehls, V
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (01): : 78 - 82
  • [43] Anti-inflammatory therapies in atrial fibrillation
    Liu, T
    Li, GP
    Huang, TG
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 104 (03) : 359 - 360
  • [44] The role of inflammatory markers in atrial fibrillation: a review
    Grigoryan, S., V
    Adamyan, K. G.
    Azarapetyan, L. G.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2012, 11 (05): : 74 - 78
  • [45] Source of inflammatory markers in patients with atrial fibrillation
    Liuba, Ioan
    Ahlmroth, Henrik
    Jonasson, Lena
    Englund, Anders
    Jonsson, Anders
    Safstrom, Kage
    Walfridsson, Hakan
    EUROPACE, 2008, 10 (07): : 848 - 853
  • [46] Inflammatory Responses to Surgery and Postoperative Atrial Fibrillation
    Karamnov, Sergey
    Muehlschlegel, Jochen D.
    ANESTHESIOLOGY, 2022, 136 (06) : 877 - 879
  • [47] Anti-inflammatory medication for atrial fibrillation
    Katritsis, DG
    EUROPEAN HEART JOURNAL, 2004, 25 (19) : 1762 - 1762
  • [48] Inflammatory markers according to types of atrial fibrillation
    Gedikli, Omer
    Dogan, Abdullah
    Altuntas, Irfan
    Altinbas, Ahmet
    Ozaydin, Mehmet
    Akturk, Onur
    Acar, Gurkan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 120 (02) : 193 - 197
  • [49] Atrial Fibrillation: An Inflammatory Disease or a Conformational Disorder?
    Goette, Andreas
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : 529 - 530
  • [50] Postoperative atrial fibrillation: The role of the inflammatory response
    Ishii, Yosuke
    Schuessler, Richard B.
    Gaynor, Sydney L.
    Hames, Kiyomi
    Damiano, Ralph J., Jr.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (06): : 1357 - 1365